Minaris Advanced Testing

The field of cell and gene therapies holds immense promise for treating a wide range of devastating diseases. However, ensuring the safety and efficacy of these novel therapies requires robust testing throughout the entire development process, from initial discovery to commercialization. Minaris Advanced Testing emerges as a key partner in this endeavor, offering a comprehensive suite of integrated testing services designed to streamline development timelines and navigate the complexities inherent in cell and gene therapies.

Understanding the unique challenges associated with these therapies is paramount. The inherent variability of biological materials, coupled with the need for meticulous safety testing on small sample sizes, necessitates a highly specialized testing environment. Minaris Advanced Testing addresses these challenges head-on with a distinguished track record of more than 40 years of experience in the field.

Their expertise extends far beyond biosafety testing. Minaris Advanced Testing boasts a team of highly qualified scientists with extensive experience in assay development, potency testing, stability studies, viral clearance, and line characterization. Their newly constructed, purpose- built state-of-the-art testing facility is located in Philadelphia, Pennsylvania.